10/08/2026
What happens when understanding how proteins misfold leads to a new way of treating disease?
At "After the Gairdner Award—Where Next?", Dr. Jeffery Kelly will explore how his research on protein aggregation led to the discovery of tafamidis, the first effective drug for slowing the progression of a human amyloid disease.
His work helped establish protein aggregation as a viable therapeutic target, catalyzing the development of additional treatments for human amyloid diseases.
Hear his talk, “Tafamidis Led to 10 Drugs for Treating Amyloid Diseases: What Remains to Do?” during in Toronto or online.
📆 October 22 | 9:00 AM ET
📍 Toronto & Online
🎟️ Free
🔗 Register: https://bit.ly/InternationalSymposium2026
Thank you to the Krembil Foundation for sponsoring this event.